Intelligent Medicine Radio for April 12, Part 1: Overactive Bladder
Medicare and Medicaid to deny coverage for weight loss drugs, as Weight Watchers files for bankruptcy; Overactive bladder may be a consequence of poor nutritional status; The paradox of how exercise helps mental fatigue; Breakthrough cases of measles may not just be about vaccine refusal; The power of urolithin A (Mitopure™️) to boost energy and slow aging.
Intelligent Medicine Radio for April 12, Part 2: Spring Allergies
“Watchdog” NGO attacks ivermectin as quack cancer fix—while studies support its potential benefits; China tariffs will impact supplements for humans—but also key nutritional ingredients for food, agriculture; Supreme Court rules on flavored vape products aimed at kids—as 17 year old cheerleader sidelined with “popcorn lung”; Tips for dealing with spring allergies.
References & Resources
Exercise as an anti-aging intervention to avoid detrimental impact of mental fatigue
Journal of Aging and Physical Activity, 2025; 1 DOI: 10.1123/japa.2024-0227
Association between geriatric nutritional risk index and overactive bladder in three elderly population: a cross-sectional study
Front. Nutr., 10 February 2025, Sec. Clinical Nutrition Volume 12 – 2025
Medicare will not cover GLP-1 drugs for weight loss
By Alice Park, time.com, April 7, 2025
Weight Watchers prepares for bankruptcy
By Alexander Glads, WSJ April 9, 2025
High school cheerleader left with ‘Deadly diagnosis’ after secretly vaping for 3 years
By Cara Lynn, AOL.com, April 9, 2025
3 essential vitamins tell the story of US dependence on China
By Willy C Shih and Veronica Chua, hbr.org, Nov 26, 2024
Hormonal birth control is associated with altered gut microbiota B-diversity in physically active females across the menstrual cycle: a pilot trial
J Appl Physiol (1985). 2025 Mar 1;138(3):739-745. doi: 10.1152/japplphysiol.00008.2025. Epub 2025 Feb 14. PMID: 39951399.
US Supreme Court largely backs FDA’s denial of flavored vape product applications
By John Kruzel, Reuters, April 2, 2025
Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma
https://pmc.ncbi.nlm.nih.gov/articles/PMC10823940
Pubmed Ivermectin, a potential anti-cancer drug derived from an antiparasitic drug
Pharmacological Research Volume 163, January 2021, 195207
False belief that cancer is a parasite leads some to believe that Ivermectin can treat it
kff.org Volume 18, March 13, 2025
